abstract |
The present invention relates to a pharmaceutical composition for the prevention or treatment of inflammatory diseases, the pharmaceutical composition comprising extracellular vesicles derived from yeast, as an active ingredient, wherein the yeast is a Komagataella genus-derived yeast and does not express a recombinant protein. |